India's No.1 Weekly For The Pharmaceutical Industry
About us || Feedback|| Advertising || Subscribe || Archives / Search 

Issue dated - 08th August 2002

Home > Edit

Editorial
Promotion, price & prohibition
The interest shown by the National Pharmaceutical Pricing Authority (NPPA) to regulate the sale of generic products by fixing retail margins is untimely, especially since the government is yet to formally announce the new Drug Price Control Order (DPCO).

Edit Article
Microbial Armageddon: Vancomycin v/s MRSA and VRE
Vancomycin is a clinically indispensable antibiotic and is the drug of last resort for treatment of multidrug-resistant infections. Bacterial resistance to vancomycin is now emerging.

INSIDE PHARMA

HAPPENNINGS

TECHNOLOGY TRENDZ

CORPORATE

EDITORIAL

POLICIES & AMEND.

SCRIPS

RESEARCH 

PRODUCT REVIEWS

AGENDA

DRUG DELIVERY
MARKETPLACE

BULK DRUG TRENDS

ARCHIVES
SUBSCRIBE
CUSTOMER SERVICE
CONTACT US
ADVERTISE
ABOUT US

 Network Sites

  Express Computer

  IT People
  Network Magazine
  Business Traveller
  Hotelier & Caterer
  Travel & Tourism
  Exp. Backwaters
  Healthcare Mgmt.
  Express Textile
 Group Sites
  ExpressIndia
  Indian Express
  Financial Express
<Top of page>
ABOUT US FEEDBACK ADVERTISE SUBSCRIBE ARCHIVES
 


© Copyright 2000: Indian Express Group (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by
The Business Publications Division of the Indian Express Group of Newspapers. Please contact our Webmaster for any queries on this site.